Kayvee Aero Pharm Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 17-12-2024
- Paid Up Capital ₹ 2.50 M
as on 17-12-2024
- Company Age 39 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.68 Cr
as on 17-12-2024
- Revenue -23.38%
(FY 2022)
- Profit -114.25%
(FY 2022)
- Ebitda -51.91%
(FY 2022)
- Net Worth -1.27%
(FY 2022)
- Total Assets -3.78%
(FY 2022)
About Kayvee Aero Pharm
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹7.68 Cr.
Kiritkumar Parikh, Bhuvan Shah, and Krishnavijay Shah serve as directors at the Company.
- CIN/LLPIN
U25231GJ1985PTC007877
- Company No.
007877
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Kayvee Aero Pharm Pvt Ltd offer?
Kayvee Aero Pharm Pvt Ltd offers a wide range of products and services, including Hospital and Medical Furniture, Hospital Equipment.
Who are the key members and board of directors at Kayvee Aero Pharm?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiritkumar Parikh  | Director | 06-Jun-1985 | Current |
Bhuvan Shah  | Director | 28-Feb-2004 | Current |
| Krishnavijay Shah | Director | 06-Jun-1985 | Current |
Financial Performance and Corporate Structure Insights of Kayvee Aero Pharm.
Kayvee Aero Pharm Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.38% decrease. The company also saw a substantial fall in profitability, with a 114.25% decrease in profit. The company's net worth dipped by a decrease of 1.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kayvee Aero Pharm?
Unlock access to Kayvee Aero Pharm's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jul 2017 | ₹4.00 Cr | Open |
Others Creation Date: 30 Jun 2017 | ₹3.68 Cr | Open |
How Many Employees Work at Kayvee Aero Pharm?
Kayvee Aero Pharm has a workforce of 20 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kayvee Aero Pharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kayvee Aero Pharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
